Dymon Asia Capital »

Cogent Biosciences shares owned by Dymon Asia Capital

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Dymon Asia Capital from 13F filings

Historical chart of Dymon Asia Capital investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Dymon Asia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Dymon Asia Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $860k 24k 35.52

More positions owned by Dymon Asia Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Silver Tr Ishares Call Option (SLV)
NVIDIA Corporation (NVDA)
Ishares Tr Mbs Etf (MBB)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Home Depot (HD)
Qualcomm (QCOM)
Synopsys Call Option (SNPS)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Dymon Asia Capital

Top funds holding Cogent Biosciences

FMR
BlackRock
Vanguard Group
Deerfield Management Company
Fairmount Funds Management
Rtw Investments
Kynam Capital Management
TCG Crossover Management
State Street Corporation
Geode Capital Management
Henderson Group
Balyasny Asset Management
Vivo Capital
Octagon Capital Advisors
Duquesne Family Office

View all funds holding Cogent Biosciences